Pharmacology Watch
RSSArticles
-
FDA Actions
-
AMPLIFY trial results
-
Safety and tolerability of statins
-
FDA Actions
-
Prostate cancer risk and 5-ARIs
-
Probiotics and antibiotic-related diarrhea
-
FDA Actions
-
Polypills for cardiovascular disease
-
Chantix safe in patients with depression
-
Medications for Risk Reduction of Breast Cancer in Women
Evidence-based updates in clinical pharmacology.
In this issue: USPSTF issues new guidelines for risk reduction of breast cancer; safety of Chantix in patients with depression; polypills for cardiovascular disease; and FDA actions.